Kathy Oubre On What Practices Can Learn About the Benefits of Implementing Biosimilars

On October 28, the Community Oncology Alliance’s (COA) hosted their virtual Payer Exchange Summit on Oncology Payment Reform which featured a panel entitled “Biosimilar Opportunities, Challenges, and Realities.” The panel, which featured Kathy Oubre, MS, chief operating officer at the Pontchartrain Cancer Center in Louisiana and member of the board of directors for COA, discussed some of the current challenges and barriers to uptake for biosimilars.

Kathy’s practice has been longtime users of biosimilars, and Kathy regularly advocates for their use. In a discussion with The Center for Biosimilars®, Kathy expanded on some of the topics she mentioned in the panel and offered other practices that may be wary of biosimilars insight into the potential benefits they could see by using them more.